Bank of England steps up to push along Co-op Bank rescue plans, amid worries buyers might be shying away from the struggling lender

whatsapp Bank of England steps up to push along Co-op Bank rescue plans, amid worries buyers might be shying away from the struggling lender Hayley Kirton Sunday 19 March 2017 3:48 pm The Bank of England’s regulatory team has begun making plans of its own for Co-op Bank, as they become increasingly impatient with the troubled lender’s sale.The Co-op Bank, which is currently 20 per cent owned by the wider Co-operative Group, revealed last month it was looking for a buyer for the whole of the business.  whatsapp Up until that point, the bank was undergoing an ambitious turnaround plan, after a £1.5bn black hole was found in its accounts in 2013. However, it announced factors like lower for longer interest rates had put a crimp in its plans to raise capital organically. Read more: OneSavings boss: If Co-op Bank sale fails we’ll pick up the piecesNow, the Sunday Telegraph reports the Prudential Regulation Authority (PRA) has become concerned no buyer will be found in the near future and has turned to external advisers to help draw up alternative plans for the lender. It is reported these plans could go as far as starting the process of winding up the bank if it is clear there is no hope on the horizon. Co-op Bank, which announced a £477m loss for 2016, has already said it might have to ask investors for as much as £750m if a suitable buyer cannot be found.Although a few potential bidders have emerged for certain parts of the lender, such as particular mortgage books, there has been less interest in buying the bank as a whole. Challenger sources have previously told City A.M. would-be buyers are put off by, among other issues, the firm’s pension scheme burden.  Share Read more: Co-op Bank blames poor performance on decision to sellIf the PRA is forced to step in, it will mark the first time the Old Lady of Threadneedle Street has done so since 2009.The Bank of England and Co-op Bank both declined to comment. by Taboolaby TaboolaSponsored LinksSponsored LinksPromoted LinksPromoted LinksYou May LikeAffluent TimesNiagara Falls Was Drained And What Was Revealed Might Make You PukeAffluent Timesillusion.funIf You See Square Waves In The Ocean Get Out Of The Water Immediatelyillusion.funHousediverShortest Men In Hollywood Their Real HeightsHousediverMaster Degree Germany | Search AdsStudying a Master Degree in Germany Might be Easier Than You ThinkMaster Degree Germany | Search Adsbest10 prohibited foods to regulate blood sugarbestTravel PatriotLittle House On The Prairie Star Karen Grassle Is 79 Now And Looks Like ThisTravel Patriot10 Best Dog for Seniors10 Best Dog for Seniors – Carammello10 Best Dog for SeniorsThe AvengersTOP-15: Stars of the movie “The Avengers” and their life partners in reality.The AvengersMoneyPailWork-From-Home Jobs In ScottsdaleMoneyPail read more

Bombardier China venture wins second high-speed train carriage contract despite diplomatic tensions

first_img whatsapp Share Thursday 13 December 2018 5:02 pm The win comes amid a growing diplomatic crisis between Ottawa and Beijing, with China having arrested two Canadians this week after Canada’s arrest of the chief financial officer of telecoms giant Huawei.China’s foreign ministry today confirmed it had detained the two, businessman Michael Spavor and former diplomat Michael Kovrig, on suspicion of endangering national security, according to Reuters.Shares were down around five per cent today. Alex Daniel Bombardier China venture wins second high-speed train carriage contract despite diplomatic tensions whatsapp Tags: Trading Archive Bombardier’s shares were down today as it announced it is to supply high-speed train cars to China’s state-owned railway company for $453m (£358.6m) as part of a joint venture (JV).The Canadian manufacturer’s 20-year-old Chinese JV, Bombardier Sifang (Qingdao) Transportation (BST), today said China Railway Corp (CRC) had awarded it the contract to supply 168 cars which will travel at speeds of up to 350 kph. The win is BST’s second this year in the growing Chinese high-speed rail market, after agreeing to supply 120 of the same cars in September for $324m.It said the timely delivery of the first batch of carriages had “earned the industry’s trust”, leading to the second order.Jianwei Zhang, president of Bombardier in China, said, “This repeat order comes just three months after the previous, clearly demonstrating the pace of development in the Chinese high-speed rail market as well as the trust that CRC has placed in our products and performance.“We are confident that our ability to consistently meet our customers’ quality, quantity, timing and cost requirements, in combination with our focus on long-term sustainable success in China, has been key to our achievements in this fiercely-competitive market.”Bombardier in China has six joint ventures, seven wholly foreign-owned enterprises, and more than 7,000 employees, the company said.last_img read more

Everyone’s Secret Boyfriend Jeff Goldblum Is the VIP Guest at This…

first_imgMediaCelebrityEveryone’s Secret Boyfriend Jeff Goldblum Is the VIP Guest at This Week’s Live Taping of Ask Me AnotherGet thee to the Ace Hotel tonight for an evening of trivia and GoldbluminessBy Marielle Wakim – May 9, 2016662ShareEmailFacebookTwitterPinterestReddItIt’s safe to assume we can all agree on one thing, and I’m not talking about the poor life decision that is Justin Bieber’s new face tattoo: Regardless of age, race, gender, sexual orientation, etc., we are all in love with Jeff Goldblum. And for good reason—he is a man who unabashedly sings during interviews and who is known to rate himself on a scale from one to ten Goldblums. (He justifiably gives himself a ten.)Most Wednesdays you can find Goldblum at the Rockwell Table and Stage in Los Feliz, where the 63-year-old actor plays jazz music and parlor games with a bar full of delighted fans. This Wednesday, however, he’ll be at the Theatre at the Ace Hotel for a live taping of NPR’s Ask Me Another, a show where audience members and call-in listeners are pelted with trivia questions and brainteasers. Goldblum will be the celebrity VIP (“Very Important Puzzler”), who has the honor of playing a custom-built game. If you’ve ever read an interview with Jeff Goldblum, you know that this is a recipe for comedy gold(blum). (If you haven’t read an interview with Jeff Goldblum, reevaluate your life and then read this one like now.) As if the episode could get any better, Weird Al will also be on hand for a portion of the evening. We give that ten Goldblums out of a possible ten Goldblums.→ Ask Me Another, Wednesday, May 11 at the Theatre at the Ace Hotel. Doors open at 6:30 p.m., show starts at 7:30 p.m. Get tickets.  TAGSWeird AlJeff GoldblumAsk Me AnythingNPRRadioAce HotelPrevious articleNew Westside Views, Courtesy of the Expo LineNext articleAll of the Cool Things You Need to Do Next Time You’re in SacramentoMarielle Wakim RELATED ARTICLESMORE FROM AUTHORToo Early for Christmas Music on the Radio? L.A.’s All-Holiday Stations Don’t Think SoKROQ Has Fired Its Entire Morning TeamGet Ready to Go Inside Jeff Goldblum’s Headlast_img read more

British Airways pairs music and menus to make airplane food taste better with Lily Allen, Paolo Nutini and Coldplay playlist

first_imgFoodies and music fans will enjoy British Airways’ latest efforts to make the experience of flying a little less painful.After its seven-hour train film to settle sleepless passengers, as well as its “happiness blanket”, comes the “Sound Bite”. That’s the pairing of music with food menus in a way that is designed to improve the taste of your dinner at 35,000 feet.Researchers at Oxford University have drawn upon a phenomenon known as “sonic seasoning” where listening to certain sounds changes the way you experience the food you’re eating or wine you’re drinking.According to BA chef Mark Tazzioli, being at such a high altitude reduces passengers’ abilities to taste by 30 per cent. So in addition to using umami-rich ingredients in its meals, the airline is now offering travellers a soundtrack to complement them.Coffee goes particularly well with Plácido Domingo’s Nessun Dorma from Turandot, as the Tenor’s lower tones are suited to the bitterness of the coffee, for example.The question is, do you choose the song that suits the food you’re eating, or the food that matches your favourite song?The playlist is available on BA’s long-haul flights from November, but if you don’t have a journey planned and want to test it out on the ground, here they are in the form of a Spotify playlist, with the menu to pair them with.StarterScottish salmonPaolo Nutini- Scream (funk my life up)Scottish musicians can enhance the provenance of Scottish foodsSavoury starterAnthony and the Johnsons- Crazy in loveorLouis Armstrong and Duke Ellington – AzaleaLow tones complement savoury startersBreakfastFull EnglishJohnny Marr, New town velocityBritish music should be paired with British foodMainBritish classicLily Allen, Somewhere only we knowPiano notes can enhance the sensation of sweet and bitter tastes.orColdplay- A sky full of starsBritish music should be paired with British foodRoast dinnerDebussy- Claire De LuneClassical music is suitable for meals such as Sunday lunch. The piano notes enhance the sensation of sweet and bitter flavoursDessertJames Blunt- You’re beautifulorMadonna- Ray of lightHigh tones boost sweet flavoursAfter dinner chocolateOtis Redding- Sitting on the dock of the bayLow tones can bring out the bitterness in chocolateDrinksRed wineThe Pretenders- Back on the chain gangRock music can enhance the depth of flavour, making red wine appear more “heavy”White wineHope/BBC Symphony Orchestra/Shostakovich- Romance from the Gadfly oOp.97Classical music can enhance the overall experience and perceptions of quality when paired with wine.CoffeePlacido Domingo- Nessun Dorma from TurandotTenors low tones are suited to the bitterness of coffee.  British Airways pairs music and menus to make airplane food taste better with Lily Allen, Paolo Nutini and Coldplay playlist Show Comments ▼ whatsapp whatsapp Wednesday 22 October 2014 8:43 am Lynsey Barber Share More From Our Partners Police Capture Elusive Tiger Poacher After 20 Years of Pursuing the Huntergoodnewsnetwork.orgFlorida woman allegedly crashes children’s birthday party, rapes teennypost.comAstounding Fossil Discovery in California After Man Looks Closelygoodnewsnetwork.orgRussell Wilson, AOC among many voicing support for Naomi Osakacbsnews.comSupermodel Anne Vyalitsyna claims income drop, pushes for child supportnypost.comNative American Tribe Gets Back Sacred Island Taken 160 Years Agogoodnewsnetwork.org980-foot skyscraper sways in China, prompting panic and evacuationsnypost.comBrave 7-Year-old Boy Swims an Hour to Rescue His Dad and Little Sistergoodnewsnetwork.orgA ProPublica investigation has caused outrage in the U.S. this weekvaluewalk.comSidney Crosby, Alex Ovechkin are graying and frayingnypost.comInside Ashton Kutcher and Mila Kunis’ not-so-average farmhouse estatenypost.comConnecticut man dies after crashing Harley into live bearnypost.comI blew off Adam Sandler 22 years ago — and it’s my biggest regretnypost.comBill Gates reportedly hoped Jeffrey Epstein would help him win a Nobelnypost.comBiden received funds from top Russia lobbyist before Nord Stream 2‘Neighbor from hell’ faces new charges after scaring off home buyersnypost.comKiller drone ‘hunted down a human target’ without being told tonypost.comMark Eaton, former NBA All-Star, dead at Tags: NULLlast_img read more

Tesco appoints DTZ to sell HQ

first_imgThursday 23 April 2015 9:25 pm whatsapp Show Comments ▼ Tesco appoints DTZ to sell HQ Express KCS whatsapp TESCO has appointed DTZ to sells its Cheshunt headquarters after the grocer’s shock decision in January to shut the office and move staff to its other corporate building in Welwyn Garden City.The property advisory firm said it is exploring selling the leasehold or the freehold of New Tesco House. It declined to comment on the price but reports suggest that it could fetch up to £17m. Tags: NULL Share Read This Next’A Quiet Place Part II’ Sets Pandemic Record in Debut WeekendFamily ProofHiking Gadgets: Amazon Deals Perfect For Your Next AdventureFamily ProofIndian Spiced Vegetable Nuggets: Recipes Worth CookingFamily ProofAmazon roars for MGM’s lion, paying $8.45 billion for studio behind JamesFamily ProofHomemade Tomato Soup: Delicious Recipes Worth CookingFamily ProofCheese Crostini: Delicious Recipes Worth CookingFamily ProofWhat is ‘Ranked-Choice Voting,’ the New System for New York’s MayoralFamily ProofChicken Bao: Delicious Recipes Worth CookingFamily ProofYoga for Beginners: 3 Different Types of Yoga You Should TryFamily Proof last_img read more

The basics: What we know — and don’t know — about the virus spreading in China and beyond

first_imgHealthThe basics: What we know — and don’t know — about the virus spreading in China and beyond Leave this field empty if you’re human: The virus, provisionally called 2019-nCoV, is a coronavirus — from the same family as the viruses that caused SARS and MERS. These viruses are generally believed to originate in bats, but they can spread to other animals before making the leap to people. The 2002-2003 SARS outbreak, for example, was traced back to palm civets and other small mammals, while MERS jumps from camels to people. Once people are infected with a virus, it’s possible they can transmit it to other people — though how easily it can spread among people depends on a number of factors. So how easily can this virus spread?Experts don’t yet know the mode of transmission — or how easily transmission can happen. Many of the cases detected initially were tied directly to the market in Wuhan. But some of the subsequent infections were clearly examples of person-to-person spread. Health officials are confident that there is at least limited person-to-person spread. But the World Health Organization has also raised the possibility that there could be ongoing, sustained transmission — meaning that the virus could transmit easily from one person to the next and then onward, like the flu.What are the symptoms of this viral infection? How dangerous is it? China alerted the WHO on Dec. 31 to an unusual burst of cases of pneumonia — an inflammation of the lungs, accompanied by cough and phlegm, that can be caused by a variety of pathogens. As health officials have learned more, they’ve seen a broader array of symptoms, according to the WHO. Overall, health authorities say, symptoms include fever, cough, and shortness of breath. A number of patients have been treated at hospitals and released within a few days. For others, the complications have been much more severe. As of Wednesday, 17 people with the infection in China had died. About the Authors Reprints Trending Now: Exclusive analysis of biopharma, health policy, and the life sciences. By looking at the rate at which coronaviruses mutate — their evolutionary clock — Rambaut has estimated when these viruses started infecting people. The sequences suggest China caught this outbreak almost immediately.“The sequence evidence suggests that the virus first cropped up in humans very, very shortly before the outbreak was identified,” Rambaut said, pointing to early December. The Chinese reported the outbreak to the WHO on Dec. 31.That suggests a remarkably finely tuned surveillance system, he said — all the more impressive because these unusual pneumonia cases were occurring during cold and flu season, when pneumonia is pretty common.What does it mean there’s now a case in the U.S.?Health authorities suggested it was only a matter of time before a case would appear in the U.S., and on Tuesday, they announced that a man in his 30s in Washington state who had traveled from Wuhan had the virus. Wuhan is a travel hub, with about 10% of the 60,000 people who travel from the city to the U.S. every year come in January because of the Lunar New Year celebrations, according to the CDC. But health authorities say that, for now, the risk to the broader American public is low. That’s based on what’s known now — but the situation is evolving very rapidly. It’s important for everyone to remember that in outbreaks, information evolves.CDC officials said they were anticipating additional cases in the U.S., likely from other travelers. All passengers coming to the country from Wuhan will now land at one of five airports — San Francisco, Los Angeles, New York’s JFK, Atlanta, and Chicago’s O’Hare — where officials are surveying passengers about their health and screening them for symptoms. The screening at the airports is meant not only to try to spot possible cases, but also serve as a reminder that people coming from Wuhan who may develop symptoms later should seek medical care. Tags Coronavirusinfectious disease It’s been only three weeks since Chinese authorities alerted the World Health Organization that it had an outbreak of unusual pneumonia cases. An astonishing amount of information has been learned in the days since about the outbreak, caused by a new virus that jumped from animals into people. But a frustrating amount of information remains still beyond our grasp.Scientists and public health officials in China and beyond are scrambling to try to learn more about the virus, which has already spread out from the Chinese city of Wuhan, where the outbreak appears to have started, to other parts of China and several other countries, including the United States. We all have more questions than answers. But here’s some of what we’ve learned about this new disease threat. advertisement How likely is it that the numbers we’re seeing reflect the actual number of infections? Not very. With most infectious diseases, there’s a spectrum of illness. With some diseases, some infections are so mild the person may have no discernible symptoms or may feel just a little off. With some diseases, the other end of the spectrum can be critical illness and death.Infectious disease experts sometimes use the analogy of an iceberg, with the really sick cases represented by the part of the iceberg that’s above the water. The people who are asymptomatic or so mildly sick they don’t seek medical attention are the part of the iceberg that doesn’t come into view. It’s not yet clear with this new disease how much of the disease we’re seeing. Until that picture comes into focus, it’s hard to put the number of deaths being reported into any useful context.Seventeen deaths out of nearly 450 cases is a fairly concerning number. If there are actually 10 times or 100 times more cases the decimal on any rough calculation of a fatality rate slides to a less alarming position. While it’s impossible to know with any degree of certainty how big this outbreak is at the moment, infectious disease epidemiologists are using mathematical models to try to come up with estimates. One group, led by Neil Ferguson of Imperial College London, estimated Friday there had been at least 1,723 cases in Wuhan alone by Jan. 12. Ferguson’s team has re-run the model, plugging in the latest available data. The new estimate, published Wednesday, suggests there were 4,000 cases in Wuhan by Jan. 18.How is this like SARS? How is it different? There are obvious similarities and sharp distinctions. Let’s start with the former.This outbreak is being caused by a coronavirus, from the same family as the virus that caused SARS. In fact, genetically this virus is similar-ish to SARS — its genetic sequence varies from the SARS epidemic virus by about 20%.Both outbreaks started in China. SARS jumped to people from small wild mammals sold as a delicacy in what are known as wet markets, where live animals can be bought and butchered on the spot. It will surprise exactly no one if this virus jumped to people in the same way.Another similarity: This outbreak is evolving super quickly, just as SARS did 17 years ago. But the differences between this outbreak and SARS are profound. Chinese authorities tried to cover up SARS for months before exported cases finally alerted the world to what was going on. This time they have been far more forthcoming, alerting the WHO, isolating a virus from a patient, sharing genetic sequences so that laboratories could design tests for the new virus, sharing information on case increases daily. This is night and day, experts say.They also appear to have discovered that a new virus had emerged really rapidly — the result, likely, of the major investment the country made in infectious diseases science after SARS.They discovered it fast? How fast?There’s no way to be certain when this coronavirus started infecting people. But by studying the available genetic sequences — 14 have been placed into international databases to date — some informed guesses can be made. Andrew Rambaut, a professor of molecular evolution at the University of Edinburgh’s Institute of Evolutionary Biology, has compared the sequences. Rambaut told STAT there is very little variation in them, suggesting they haven’t been spreading in people for very long. A woman wears a mask while at the subway station in Wuhan, China. Getty Images Please enter a valid email address. Senior Writer, Infectious Disease Helen covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson It’s been sequenced. It’s spread across borders. Now the new pneumonia-causing virus needs a name Related: General Assignment Reporter Andrew covers a range of topics, from addiction to public health to genetics. @DrewQJoseph @HelenBranswell [email protected] Andrew Joseph Newsletters Sign up for Daily Recap A roundup of STAT’s top stories of the day. Privacy Policy Where did the virus come from? Health officials in China tracked many of the initial cases to a large seafood market in Wuhan, a city in central China, that also sold wild animals as meat. The leader of an expert committee working on the outbreak has said some type of game is the most likely source.advertisement Helen Branswell STAT+: It’s possible that some people have such mild symptoms they’re not seeking medical care or that health authorities have missed some of these mild cases. That makes it hard to know how dangerous the virus is to most people, and it remains very early in the outbreak. The WHO said this week that of 278 confirmed cases in China, 51 people are severely ill, with 12 in critical condition. “A major concern is the range of severity of symptoms this virus is causing,” Jeremy Farrar, the director of the Wellcome Trust, said in a statement Tuesday. “It is clear some people are being affected and are infectious while experiencing only very mild symptoms or possibly without experiencing symptoms at all (asymptomatic). This may be masking the true numbers infected and the extent of person to person transmission. It is a matter of urgency to work this out.”One common thread among most of the fatal cases is that the patients had other health problems. The first death was a 61-year-old man who also had abdominal tumors and chronic liver disease. Two deaths reported Tuesday — the fifth and sixth of the outbreak — were a 66-year-old man with COPD, hypertension, and other conditions, and a 48-year-old woman who had diabetes and who had had a stroke. Why has the number of cases spiked so quickly? There’s no disputing the case count has risen sharply. As of Friday, local health officials in Wuhan had confirmed 45 cases, with three identified “exported” cases in Thailand and Japan. By Wednesday, there were nearly 450 confirmed cases in China. There are a few possible explanations for the spike. One is that the virus is simply spreading quickly on its own. But when you’re looking for something, you’re also more likely to spot it. As awareness about the virus increased, and health authorities throughout China and in other countries started keeping an eye out, they started investigating cases of respiratory infections more rigorously. People with symptoms may have been more likely to seek out medical care. Plus, researchers have publicly released the genetic sequences of virus they’ve collected, which allows for conclusive diagnosis. There’s also the political factor. Chinese President Xi Jinping said Monday that the outbreak “must be taken seriously” and that “party committees, governments, and relevant departments at all levels should put people’s lives and health first.” This was seen as a signal from the country’s leader that officials should be transparent about the scope of the outbreak as opposed to restricting information.  By Andrew Joseph and Helen Branswell Jan. 22, 2020 Reprintslast_img read more

‘Small’ tactics to counter Big Pharma’s influence on medication overload

first_img By Shannon Brownlee and Judith Garber Jan. 28, 2020 Reprints @LownInstitute This is no minor problem. In “Medication Overload: America’s Other Drug Problem,” a report issued last year by the Lown Institute, we estimated that 1 in 5 older Americans — that’s 10 million people — experienced an adverse drug event in 2018. More than one-quarter million were hospitalized because of a medication reaction. Over the next decade, adverse drug events can be expected to cause 4.6 million hospitalizations of older Americans, 74 million outpatient visits, and nearly 150,000 premature deaths.advertisement Want to know how contentious drug pricing is in Washington? Check the receipts Related: Tags advocacypatientspharmaceuticalsphysicians Shannon Brownlee To address the epidemic of medication overload, we worked with a group of experts on medication use to develop a national action plan, which we released today. In it, the powerful influence exerted by pharmaceutical marketing came up time and again as a key driver of overprescribing.The pharmaceutical industry spends $26 billion a year marketing to clinicians and patients because it works. Physicians are more likely to prescribe drugs they receive as free samples; free lunches double the likelihood physicians will prescribe a brand-name drug over a generic; visits from sales reps increase prescribing of a company’s drug; and when patients “ask their doctor” about a medication — something that many ads recommend doing — doctors are more likely to prescribe it.The path toward regulating that marketing is strewn with obstacles. Despite support from many clinicians and the American Medical Association, recent efforts by members of Congress to ban or limit direct-to-consumer drug ads have been stymied by industry lobbying. Two bills introduced in 2019, one to ban ads for three years after the approval of a new drug and another to remove the tax deduction for drug ads, have not advanced. Even on a local level, a 2019 Philadelphia city council proposal to regulate drug company sales reps was quashed amid strong industry pressure.The immense political power of the pharmaceutical industry is a barrier to change, but that doesn’t mean that change is impossible. Federal and local legislators should continue to propose legislation to ban direct-to-consumer pharmaceutical marketing, or at least regulate it so the information presented is more balanced. In the meantime, clinicians, patients, and policymakers can pursue other avenues to reduce pharmaceutical industry influence. Here are five possible strategies:Refuse to see drug reps. Clinicians can adopt pharma-free policies for their own practices and refuse to accept food, gifts, visits with drug reps, or free samples. These clinicians should display their pharma-free status proudly, and invite conversations with other clinicians and patients about why they made this decision. Leave this field empty if you’re human: Advocate for pharma-free facilities. Health care institutions can also become pharma free and ban or limit access by sales reps within the hospital or clinic. Many academic medical centers have limited such access, which has led to fewer prescriptions of marketed drugs and more appropriate prescribing. Academic medical centers instituted these policies partly in response to pressure from the American Medical Student Association. Clinicians at other hospitals or clinics should similarly band together and demand pharma-free work environments for the sake of their patients.Choose pharma-free clinicians. Patients should be able to choose to see pharma-free doctors. Those who want to exercise this option should take into account whether the doctor accepts gifts from pharma, and how much. Patients can find useful information about that at the Open Payments database, which is run by the Centers for Medicare and Medicaid Services, though it does not include information on whether doctors accept free samples. The acceptance of samples should be incorporated into Open Payments and similar databases, such as ProPublica’s “Dollars For Docs,” to make it easier for patients to find pharma-free clinicians.Regulate drug samples. Current regulations make it easy for prescribers to accept drug samples because the requirements for storing and dispensing samples are lax. Clinical practices are allowed to keep drug samples in a “sample closet,” which often becomes a disorganized heap of pill bottles that stay in the closet far past their expiration dates. If clinicians had to comply with safe drug storage practices for drug samples and knew the rules would be enforced, they might reconsider whether accepting free samples was worth it for their practices and their patients.Popularize the Drug Facts box. Patients need a clear answer to the question: “How many patients like me will be helped by this drug, and how many will be harmed?” Fortunately, there’s an effective tool that conveys this information. The Drug Facts box, developed by Dartmouth Institute researchers Lisa Schwartz and Steve Woloshin, is a standardized, single-page format for conveying drug effectiveness and risk of harm. Like the Nutrition Facts box that by law must appear on packaged foods and beverages, the Drug Facts box gives patients clear information on the proportion of people who benefit from a drug compared to people who take a placebo.While viewers of an ad for sleep aid Lunesta may be seduced by calming images of a good night’s sleep, readers of the Drug Facts box will know that Lunesta improves time to sleep by just 15 minutes compared to a placebo. Drug Facts boxes created by independent researchers should be required to be printed alongside print and online ads, and added to television ads whenever possible.Big Pharma’s political power is formidable, but there are plenty of ways in which patients, clinicians, and health care institutions can take matters into their own hands and reduce medication overload.Shannon Brownlee is senior vice president of the Lown Institute and author of “Overtreated: Why Too Much Medicine is Making Us Sicker and Poorer” (Bloomsbury, 2007). Judith Garber is a health care policy and communications fellow at the Lown Institute and writer of “Eliminating Medication Overload: A National Action Plan.“ Money talks in Washington, D.C., and no sector of the economy speaks more loudly than the pharmaceutical and biotech industry. Its flow of cash has fostered an epidemic of medication overload.Over the past five years, pharma has spent about $1.2 billion lobbying federal lawmakers, far more than any other industry. The industry has massive influence over public policy, much of it devoted in recent months to hindering legislative efforts to lower drug prices.In addition to keeping prices high, the industry has protected its freedom to market its products. A series of Supreme Court rulings from the 1970s through the 1990s opened the floodgates to direct-to-consumer drug ads in print and broadcast media.advertisementcenter_img @ShannonBrownlee Newsletters Sign up for D.C. Diagnosis An insider’s guide to the politics and policies of health care. First Opinion‘Small’ tactics to counter Big Pharma’s influence on medication overload Privacy Policy About the Authors Reprints Adobe Judith Garber Please enter a valid email address. Those ads, together with marketing to clinicians — in the form of visits from drug reps, free samples, free lunches, continuing education, and more — has created a pervasive culture of prescribing in which patients and clinicians expect a pill to cure every ill. Thanks in part to this cultural norm, nearly half of Americans over the age of 65 take at least five medications a day, and almost 20% take more than 10.last_img read more

Tiny Denmark saved lots of money on biosimilar Humira, while Americans are still paying big bucks

first_img What’s included? Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. David J. Phillip/AP Log In | Learn More Pharmalot Columnist, Senior Writer Ed covers the pharmaceutical industry. Tags BiosimilarsSTAT+ @Pharmalot About the Author Reprints Tiny Denmark saved lots of money on biosimilar Humira, while Americans are still paying big bucks center_img Pharmalot What is it? GET STARTED Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+. First 30 days free. GET STARTED Ed Silverman [email protected] By Ed Silverman June 3, 2020 Reprints For those yearning for the day when biosimilars save the U.S. health care system huge amounts of money, consider a recent episode in Denmark.In October 2018, the patent expired on Humira, a big-selling biologic drug that is used to treat rheumatoid arthritis, Crohn’s disease, and other ailments. The Danish government moved quickly and began accepting bids from companies that make biosimilar versions, which are nearly identical variants that are expected to yield the same health outcomes, but cost less than pricey brand-name biologics.last_img read more

Senior Secured Floating Rate Loan Fund files prospectus

IE Staff The closed-end fund has been created to invest in an actively managed portfolio consisting primarily of first lien senior secured floating rate corporate loans of U.S. borrowers. The fund’s investment objectives are to provide unitholders with stable monthly cash distributions, preservation of capital and increased returns in the event that short-term interest rates rise. Initial distributions are targeted to be 6.5% per year based on the subscription price of $10 ($0.054167 per unit per month, or $0.65 per unit per year). Propel has retained Credit Suisse Asset Management, LLC to provide portfolio management services to the fund. Credit Suisse has approximately U.S. $400 billion in assets under management, including over U.S. $19 billion in senior secured loans. The syndicate of agents for this offering is being led by CIBC, National Bank Financial Inc., RBC Capital Markets, and TD Securities Inc., and includes BMO Capital Markets, GMP Securities L.P., Scotiabank, Raymond James Ltd., Canaccord Genuity Corp., Macquarie Private Wealth Inc., Desjardins Securities Inc., Dundee Securities Ltd. and Manulife Securities Inc. Senior Secured Floating Rate Loan Fund has filed a preliminary prospectus for an initial public offering of units, Toronto-based Propel Capital Corp., the manager and promoter of the fund, said Wednesday Class A units will be priced at $10 per unit, and Class U Units, designed for investors who want to make their investment in U.S. dollars, will be available at US$10 per unit. Related news Digital Consumer Dividend Fund files IPO Share this article and your comments with peers on social media Keywords Closed-end funds Faircourt migrates two closed-end funds to NEO Europe Blue-Chip Dividend & Growth Fund confirms termination date Facebook LinkedIn Twitter read more

Team Jamaica Programme Enhancing Skills of Hospitality Workers

first_imgRelatedTeam Jamaica Programme Enhancing Skills of Hospitality Workers Advertisements RelatedTeam Jamaica Programme Enhancing Skills of Hospitality Workers Team Jamaica Programme Enhancing Skills of Hospitality Workers UncategorizedNovember 23, 2006center_img FacebookTwitterWhatsAppEmail ‘Together Everyone Achieves More’, is the mantra that characterises Team Jamaica, a mandatory training and certification programme conducted by the Tourism Product Development Company (TPDCo) for persons employed or associated with the hospitality and tourism sector.The programme was developed in 1997 by an Advisory Council comprising both private and public sector tourism organizations including: The Ministry of Industry and Tourism, TPDCo, the Jamaica Tourist Board, the Jamaica Hotel and Tourist Association, the HEART Trust/NTA and the Chambers of Commerce.To date, TPDCo has trained 16,400 persons under the programme, ranging from hotel executives, waiters, and front office attendants to security personnel.Speaking with JIS News, Executive Training Manager at TPDCo, Hugh Shim explains that the Company introduced the programme on a directive from the Ministry of Industry and Tourism, that all 70,000 workers in the tourism sector must be exposed to training and certification.“It is our strong belief that the tourism product must first be experienced, sampled and accepted by our people, as it enhances their ability to market the services and facilities with pride to our visitors,” Mr. Shim points out.He adds that the main purpose of the programme therefore, is to “create a quality tourism team aimed at building team spirit, pride in self and country, and to certify participants as trained tourism personnel”.He notes that the Team Jamaica certification is a requirement for obtaining a Jamaica Tourist Board licence and work permits for the tourism sector.In terms of the duration of the programme, Mr. Shim explains that Team Jamaica runs for two weeks at a cost of $3,500.00 and facilitates 12 to 25 participants at each session. He notes that different regions are targeted each month but the programme may run for a longer period in areas that are heavily populated with tourists. These areas include Negril, Ocho Rios, and Montego Bay.The training modules cover tourism awareness, customer service, self-development, Jamaican history, geography, attractions, culture (cuisine and music), environmental awareness, a challenge quiz and an oral presentation.One key beneficiary of the programme is taxi operator, Laurence McGregor who describes the programme as “interesting and a learning process”.“The course has helped me to communicate better with the visitors and highlight Jamaica in a positive way and since tourism is a competitive business, I am now able to stay ahead of the game and equipped for the visitors. I can also pass on what I have learnt to fellow drivers,” Mr. McGregor points out.In addition to workers within the tourism sector, Mr. Shim notes that the training programme has to be pursued by “all hospitality students from the University of Technology, the community colleges and HEART”.Annually, approximately 1,600 persons are trained directly by TPDCo while the HEART Trust NTA trains an additional 3,200 persons based on a Memorandum of Understanding signed between the two agencies in April 2004.Mr. Shim states that the collaboration with HEART has continued over the years with the most recent thrust being the launch of the Team Jamaica Self-Teaching CD-Rom. The level 1 CD-ROM is designed for use as an instrumental tool and self-teaching courseware, and it is anticipated that its introduction will increase training in the tourism sector by 30 per cent.According to Mr. Shim, the self-teaching CD-ROM “gives more flexibility to the delivery and learning of the programme” and is suitable for persons with “heavy schedules, complicated working hours”, and who would not be able to attend the regular classroom sessions.The Team Jamaica training and certification programme has five levels: level one is for team members, while level two is for supervisors, level three for line managers, level four for general managers, and level five for instructors of the programme.For further information on the Team Jamaica programme, persons may contact TPDCo at (876) 968-3441/3626 or visit the website at RelatedTeam Jamaica Programme Enhancing Skills of Hospitality Workerslast_img read more